Gevo stock stood at EUR 1.04 with a minus 1.30 earnings multiple

Published on 10/17/2026 at 20:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gevo's next results are estimated for November 9, 2026. Gevo stock stood at EUR 1.04 on October 16, 2026, down 0.48 percent versus the Tradegate close.

Valuation and reporting date

Gevo's price-to-earnings ratio was minus 1.30 on October 16, 2026.
Aemetis gained 1.04 percent on October 16, 2026, with a USD 105.4 million market value.
Gevo stock stood at EUR 1.04 on October 16, 2026 at 2:38 p.m. CEST, down 0.48 percent versus the Tradegate close of October 15, 2026.
Gevo's next results are estimated for November 9, 2026.

GEVO, US3743964062, Illustration mit AI erstellt.

Gevo stock stood at EUR 1.04 on October 16, 2026 at 2:38 p.m. CEST, down 0.48 percent versus the Tradegate close of October 15, 2026. The price frame is accompanied by a negative price-to-earnings ratio of 1.30 and a market capitalization of USD 289.3 million.

Valuation remains the key measure

The latest quote data put Gevo's price-to-earnings ratio at minus 1.30 and its market value at USD 289.3 million. The figure is a market snapshot rather than a profitability signal, because a negative ratio reflects losses rather than a conventional earnings multiple.

Gevo's last reported quarter ended June 30, 2026. Standardized financial data show revenue of USD 46.5 million and a net loss attributable to common shareholders of USD 176.9 million for that quarter. The loss figure is unusually large relative to revenue and requires care when comparing valuation measures.

Range and annual performance

Gevo's primary listing is Nasdaq, where the October 16, 2026 quote was USD 1.17 at 4:00 p.m. ET. The 52-week range was USD 1.15 to USD 2.97, placing the stock USD 0.02 above its yearly low and USD 1.80 below its yearly high. A September 4 market snapshot put the year-to-date performance at minus 19.00 percent, according to Marketscreener.

Results date points to November

Gevo's next quarterly results are estimated for November 9, 2026, after the market close, with a conference call scheduled for 4:30 p.m. ET. MarketBeat identifies the date as an estimate rather than a company-confirmed calendar entry.

Comparison with peers

Gevo: minus 0.48 percent, price-to-earnings ratio minus 1.30, market capitalization USD 289.3 million
Aemetis (Nasdaq, USD): plus 1.04 percent, price-to-earnings ratio minus 1.60, market capitalization USD 105.4 million
Origin Materials (Nasdaq, USD): minus 0.00 percent, price-to-earnings ratio minus 0.02, market capitalization USD 5.2 million

What the quote says

The combination of a price near the yearly low, a negative earnings multiple and a scheduled November reporting date leaves operating performance as the next concrete valuation reference. The October 16 Tradegate quote stood at EUR 1.04 at 2:38 p.m. CEST, down 0.48 percent versus the Tradegate close of October 15, 2026.